{"DataElement":{"publicId":"4179203","version":"1","preferredName":"Advanced Adenoma Finding Lesion Count","preferredDefinition":"The response regarding the quantity of adenomas that have been identified that are pathologically advanced.","longName":"ADV_ADEN_LES_CT","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"4179202","version":"1","preferredName":"Advanced Adenoma Finding","preferredDefinition":"Far along in course._A neoplasm arising from the epithelium.  It may be encapsulated or non-encapsulated but non-invasive.  The neoplastic epithelial cells may or may not display cellular atypia or dysplasia.  In the gastrointestinal tract, when dysplasia becomes severe it is sometimes called carcinoma in situ.  Representative examples are pituitary gland adenoma, follicular adenoma of the thyroid gland, and adenomas (or adenomatous polyps) of the gastrointestinal tract._Clinical, laboratory or molecular evidence, or absence of evidence of disease.","longName":"4179200v1.0:2241301v1.0","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"4179200","version":"1","preferredName":"Advanced Adenoma","preferredDefinition":"Far along in course.:A neoplasm arising from the epithelium.  It may be encapsulated or non-encapsulated but non-invasive.  The neoplastic epithelial cells may or may not display cellular atypia or dysplasia.  In the gastrointestinal tract, when dysplasia becomes severe it is sometimes called carcinoma in situ.  Representative examples are pituitary gland adenoma, follicular adenoma of the thyroid gland, and adenomas (or adenomatous polyps) of the gastrointestinal tract.","longName":"C25411:C2855","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Advanced","conceptCode":"C25411","definition":"Far along in course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenoma","conceptCode":"C2855","definition":"A neoplasm arising from the epithelium.  It may be encapsulated or non-encapsulated but non-invasive.  The neoplastic epithelial cells may or may not display cellular atypia or dysplasia.  In the gastrointestinal tract, when dysplasia becomes severe it is sometimes called carcinoma in situ.  Representative examples are pituitary gland adenoma, follicular adenoma of the thyroid gland, and adenomas (or adenomatous polyps) of the gastrointestinal tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F357112E-3835-A143-E040-BB89AD43336C","latestVersionIndicator":"Yes","beginDate":"2014-02-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-02-26","modifiedBy":"ONEDATA","dateModified":"2014-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241301","version":"1","preferredName":"Finding","preferredDefinition":"Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.","longName":"C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FAB2D8EC-6E04-68CB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F357112E-3843-A143-E040-BB89AD43336C","latestVersionIndicator":"Yes","beginDate":"2014-02-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-02-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"MAY2013-01-01_02-26-14_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018596","version":"1","preferredName":"Lesion Count","preferredDefinition":"the quantity of specified lesions.","longName":"LES_CT","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184284","version":"1","preferredName":"Count","preferredDefinition":"Count; the total number counted","longName":"Count","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Count","conceptCode":"C25463","definition":"Determining the number or amount of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1AE6-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B67C2956-C2E6-040D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-12","modifiedBy":"KNABLEJ","dateModified":"2018-10-23","changeDescription":"10/23/18 jk chg reg status to Standard as part of RECIST FG content; reused by 24 CDEs and multiple SOs.  10-19-2018 TMT received permission from BC to transfer ownership from CTEP to NCI Standards.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"4261411","version":"1","longName":"MAY2013-01-01","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Total number of advanced aden","type":"Preferred Question Text","description":"Total number of advanced adenomas","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F357112E-3858-A143-E040-BB89AD43336C","latestVersionIndicator":"Yes","beginDate":"2014-02-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-02-26","modifiedBy":"MAESKEB","dateModified":"2014-04-21","changeDescription":"MAY01-01_02-26-14_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}